Rémi Gagnon

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial”.

Oral once-daily berotralstat for the prevention of hereditary angioedema attacks: A randomized, double-blind, placebo-controlled phase 3 trial

Journal of Allergy and Clinical Immunology(2020)10.1016/j.jaci.2020.10.015

N/A

5.2DataRank · unranked

164 citations

William R. Lumry, Douglas Johnston, Emel Aygören‐Pürsün, Aleena Banerji, Jonathan A. Bernstein +31 more

Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study)

The Journal of Allergy and Clinical Immunology In Practice(2025)10.1016/j.jaip.2025.02.024

N/A

0.311DataRank · unranked

6 citations

Rémi Gagnon, Gordon Sussman, Dareen Siri, Roxanne C. Oriel, Terri F. Brown‐Whitehorn +29 more

The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.06.006

N/A

0DataRank · unranked

210 citations

Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David A. Khan, Cem Akin +58 more

Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: REALISE Randomized Clinical Trial Results

The Journal of Allergy and Clinical Immunology In Practice(2021)10.1016/j.jaip.2021.11.017

N/A

0DataRank · unranked

62 citations

Rémi Gagnon, Gordon L. Sussman, Dareen Siri, Roxanne C. Oriel, Terri F. Brown‐Whitehorn +31 more

Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach

Journal of Allergy and Clinical Immunology(2023)10.1016/j.jaci.2023.05.019

N/A

0DataRank · unranked

23 citations

Timothy E. Dribin, Elissa M. Abrams, Marcus Shaker, Derek K. Chu, David B.K. Golden +89 more